Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Atorvastatin on the Nitric Oxide-system in Patients With Non-diabetic Nephropathy

NCT01213498 is registered in ClinicalTrials.gov with Erling Bjerregaard Pedersen as lead sponsor.

NCT NCT01213498
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01213498 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Atorvastatin on the Nitric Oxide-system in Patients With Non-diabetic Nephropathy
Lead sponsor
Erling Bjerregaard Pedersen
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2010
Completion date
January 31, 2012
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, nephropathy